scispace - formally typeset
J

Jeroen Raes

Researcher at Katholieke Universiteit Leuven

Publications -  293
Citations -  85097

Jeroen Raes is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Microbiome & Medicine. The author has an hindex of 84, co-authored 240 publications receiving 66805 citations. Previous affiliations of Jeroen Raes include Flanders Institute for Biotechnology & Université catholique de Louvain.

Papers
More filters
Journal ArticleDOI

Introducing insoluble wheat bran as a gut microbiota niche in an in vitro dynamic gut model stimulates propionate and butyrate production and induces colon region specific shifts in the luminal and mucosal microbial community

TL;DR: The long-term effects of insoluble wheat bran supplementation on the composition and functionality of the gut microbial community derived from six individuals were explored in the Dietary Particle-Mucosal-Simulator of the human gut ecosystem in vitro model.
Journal ArticleDOI

Design of synthetic microbial consortia for gut microbiota modulation.

TL;DR: The steps in the process for identifying effective targets, predicting putative multistrain communities, assembling ecosystems in silico and in vitro and monitoring stability and outputs before in vivo trials are discussed.
Journal ArticleDOI

A nitrile hydratase in the eukaryote Monosiga brevicollis.

TL;DR: The two usually separated NHase subunits fused in one protein of the choanoflagellate Monosiga brevicollis, a recently sequenced unicellular model organism from the closest sister group of Metazoa, implying a probable ancient horizontal gene transfer from proteobacteria.
Journal ArticleDOI

A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine

TL;DR: The aims of this multidisciplinary collaboration are to identify molecular signatures of prognostic value to help tailor treatment decisions to an individual likely to initiate TNF inhibitor therapy, followed by lifestyle factors that support achievement of optimised treatment outcome.